Empirical Financial Services, LLC d.b.a. Empirical Wealth Management

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1510434 Seattle, WA

Back to HRMY Full portfolio

Position in HRMY

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$430,766

+$175,456 QoQ

Shares Held

11,831

+29.8% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#12

of 24 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 96.25559969571465.ToString("F0")% Shared 0.ToString("F0")% None 3.744400304285352.ToString("F0")%

Common Shares in HRMY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $12,687,043 across 17 Biotechnology names. HRMY ranks #7 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	73,041	$2,295,678
2	INBX	Inhibrx Biosciences, Inc.	22,584	$2,139,834
3	ORKA	Oruka Therapeutics, Inc.	19,312	$1,837,923
4	JAZZ	Jazz Pharmaceuticals plc	7,464	$1,798,599
5	PTCT	Ptc Therapeutics, Inc.	15,916	$1,298,267
6	EXEL	Exelixis, Inc.	10,083	$548,615
7	HRMY	Harmony Biosciences Holdings, Inc. This page	11,831	$430,766
8	ACAD	Acadia Pharmaceuticals Inc	15,489	$391,871

All Filings in HRMY

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$430,766	11,831	+29.8%	Shares	Sole	2026-07-15
2026-03-31	$255,310	9,115	+31.0%	Shares	Sole	2026-05-04
2025-12-31	$260,443	6,960	—	Shares	Sole	2026-01-16
No filing history on record for this holder in this stock.